世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のバイオ外科手術市場予測 2018-2026年

GLOBAL BIOSURGERY MARKET FORECAST 2018-2026

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年4月US$2,500
シングルユーザライセンス
135

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界のバイオ外科手術市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
Driven by the increase in treatments and surgeries involving musculoskeletal disorders, rising trauma-related injuries and increasing sophistication of biocompatible synthetic bone grafts, the global biosurgery market is anticipated to grow at a CAGR of 8.03% over the forecast years of 2018-2026.
MARKET INSIGHTS
The global bio-surgery market is segmented on the basis of products, source types and applications. The products segment includes hemostatic agents, soft tissue management, bone graft substitutes, anti-adhesive agents and surgical sealing agents. By source type, the global bio-surgery market can be divided into natural and synthetic sources. The application segments include cardio and thoracic surgery, neuro and spine surgery, orthopaedic surgery and general surgery.
REGIONAL INSIGHTS
Region-wise, the global biosurgery market is segmented into Asia-Pacific, North America, Europe and rest of the world. North America biosurgery market accounted for the highest revenue share in 2017. Mexico, Canada and the US are the major markets in this region. The region has witnessed tremendous technological advancements in the recent years. However, the Asia-Pacific market is predicted to account for the highest CAGR by the end of the forecast period. The region has a brimming ageing population, which coupled with the rising number of chronic cases is propelling this market’s growth.
COMPETITIVE INSIGHTS
Some eminent companies in this market include Baxter International Inc, B. Braun Melsungen Ag, Ethicon Inc, Johnson & Johnson, Exatech Inc, Medtronic Plc, RTI Surgical, Olympus Corporation, Smith & Nephew Plc, Sanofi, Stryker Corporation, Ypsomed Holding Ag, Wright Medical Group N.V, and Zimmer Biomet Holdings Inc.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. SURGICAL SEALING AGENTS ARE GROWING AT A SIGNIFICANT RATE
3.2.2. GENERAL SURGERY IS EXPECTED TO EMERGE AS THE FASTEST-GROWING SEGMENT
3.2.3. NATURAL SOURCE TYPE HOLDS THE LARGEST MARKET SHARE
3.2.4. NORTH AMERICA IS THE BIGGER MARKET FOR BIOSURGERY
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
4.1.2. AGEING POPULATION IN KEY COUNTRIES
4.1.3. INCREASING SOPHISTICATION OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
4.1.4. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
4.1.5. RISING TRAUMA RELATED INJURIES
4.1.6. INCREASE IN THE GLOBAL OBESE POPULATION
4.1.7. ADVANTAGES OF BIOSURGERY OVER TRADITIONAL SURGICAL METHODS
4.2. MARKET RESTRAINTS
4.2.1. INCREMENTAL RISE IN THE COST OF SURGERIES
4.2.2. THE STRINGENT REGULATORY APPROVAL PROCESS
4.2.3. LACK OF AWARENESS AND SOCIETAL DISAPPROVAL
4.2.4. RISING ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES
4.2.5. POST-SURGERY COMPLICATIONS IN ORTHOPEDIC SURGERY
4.3. MARKET OPPORTUNITIES
4.3.1. RESEARCH AND INVESTMENT IN BIOENGINEERING LEADING TO THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
4.3.2. RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
4.3.3. INCREASE IN THE RESEARCH AND DEVELOPMENT
4.3.4. HUGE SPENDING ON THE HEALTHCARE
4.3.5. PRESENCE OF MULTIFUNCTIONAL PRODUCTS
4.4. MARKET CHALLENGES
4.4.1. SURGICAL RISK RELATED TO REJECTION DUE TO IMMUNE RESPONSE
4.4.2. INCREASED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
4.4.3. PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
4.4.4. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
5. MARKET SEGMENTATION
5.1. MARKET BY PRODUCTS 2018-2026
5.1.1. BONE-GRAFT SUBSTITUTES
5.1.1.1. SYNTHETIC GRAFT EXTENDER
5.1.1.2. DEMINERALIZED BONE MATRIX
5.1.1.3. BONE MORPHOGENETIC PROTEINS
5.1.1.4. CELL-BASED MATRICES
5.1.2. HEMOSTATIC AGENTS
5.1.3. SOFT-TISSUE MANAGEMENT
5.1.3.1. SYNTHETIC MESH/PATCH
5.1.3.2. NATURAL MESH/PATCH
5.1.4. SURGICAL SEALING AGENTS
5.1.4.1. NATURAL SURGICAL SEALING AGENTS
5.1.4.2. SYNTHETIC SURGICAL SEALING AGENTS
5.1.5. ANTI-ADHESIVE AGENTS
5.2. MARKET BY APPLICATION 2018-2026
5.2.1. NEURO AND SPINE SURGERY
5.2.2. CARDIO AND THORACIC SURGERY
5.2.3. GENERAL SURGERY
5.2.4. ORTHOPEDIC SURGERY
5.2.4.1. MARKET TRENDS IN ORTHOPEDIC PROCEDURES
5.2.4.1.1. IMPLEMENTATION OF ROBOTIC SURGICAL PROCEDURES
5.2.4.1.2. GROWTH IN ORTHOPEDIC SUBCONTRACTING
5.2.4.1.3. UPSURGE IN ACCEPTANCE OF NEW ORTHOPEDIC PRODUCTS
5.3. MARKET BY SOURCE TYPE 2018-2026
5.3.1. NATURAL
5.3.2. SYNTHETIC
6. KEY ANALYTICS
6.1. MARKET ETYMOLOGY
6.2. REGULATORY FRAMEWORK
6.3. TECHNOLOGICAL TRENDS
6.4. KEY VENDORS STRATEGIES IN BIOSURGERY MARKET
6.5. KEY BUYING CRITERIA
6.6. PATENT ANALYSIS
6.6.1. THE UNITED STATES PATENT ANALYSIS
6.6.2. EUROPE PATENT ANALYSIS
6.6.3. ASIA PACIFIC PATENT ANALYSIS
6.6.3.1. JAPAN PATENT ANALYSIS
6.6.3.2. CHINA PATENT ANALYSIS
6.6.3.3. KOREA PATENT ANALYSIS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. THE UNITED STATES
7.1.2. CANADA
7.1.3. MEXICO
7.2. EUROPE
7.2.1. GERMANY
7.2.2. THE UNITED KINGDOM
7.2.3. FRANCE
7.2.4. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. INDIA
7.3.4. AUSTRALIA
7.3.5. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST
7.4.3. AFRICA
8. COMPANY PROFILES
8.1. B. BRAUN MELSUNGEN AG
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. SWOT ANALYSIS
8.1.4. STRATEGIC INITIATIVES
8.2. BAXTER INTERNATIONAL INC.
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVES
8.3. ETHICON INC.
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. STRATEGIC INITIATIVES
8.4. EXATECH INC
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SCOT
8.5. JOHNSON & JOHNSON
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SWOT ANALYSIS
8.5.4. STRATEGIC INITIATIVES
8.6. MEDTRONIC PLC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SWOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. OLYMPUS CORPORATION
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. RTI SURGICAL
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVES
8.9. SANOFI
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCTS PORTFOLIO
8.9.3. SWOT ANALYSIS
8.9.4. STRATEGIC INITIATIVES
8.10. SMITH & NEPHEW PLC
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVES
8.11. STRYKER CORPORATION
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVES
8.12. WRIGHT MEDICAL GROUP N.V.
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.12.4. STRATEGIC INITIATIVES
8.13. YPSOMED HOLDING AG
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCTS PORTFOLIO
8.13.3. SWOT ANALYSIS
8.13.4. STRATEGIC INITIATIVES
8.14. ZIMMER BIOMET HOLDINGS INC.
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES

TABLE LIST
TABLE 1 GLOBAL BIOSURGERY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 GLOBAL BIOSURGERY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 5 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 6 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY TYPES 2018-2026 ($ MILLION)
TABLE 7 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 8 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN SYNTHETIC GRAFT EXTENDERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN DEMINERALIZED BONE MATRIX BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 10 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN BONE MORPHOGENETIC PROTEINS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN CELL-BASED MATRICES BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 12 GLOBAL BIOSURGERY MARKET IN HEMOSTATIC AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 13 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 15 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 16 GLOBAL SOFT-TISSUE MANAGEMENT MARKET IN BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 17 GLOBAL SOFT-TISSUE MANAGEMENT MARKET IN BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 18 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 19 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 20 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 21 GLOBAL SURGICAL SEALING AGENTS MARKET IN NATURAL BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 22 GLOBAL SURGICAL SEALING AGENTS MARKET IN SYNTHETIC BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 23 GLOBAL BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 24 GLOBAL BIOSURGERY MARKET BY APPLICATIONS 2018-2026 ($ MILLION)
TABLE 25 GLOBAL BIOSURGERY MARKET IN NEURO AND SPINE SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 26 GLOBAL BIOSURGERY MARKET IN CARDIO AND THORACIC SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 27 TYPES OF CARDIOVASCULAR DISEASES
TABLE 28 GLOBAL BIOSURGERY MARKET IN GENERAL SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 29 GLOBAL BIOSURGERY MARKET IN ORTHOPEDIC SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 30 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 31 GLOBAL BIOSURGERY MARKET BY SOURCE TYPE 2018-2026
TABLE 32 GLOBAL BIOSURGERY MARKET IN NATURAL BY GEOGRAPHY 2018-2026
TABLE 33 GLOBAL BIOSURGERY MARKET IN SYNTHETIC BY GEOGRAPHY 2018-2026
TABLE 34 MEDICAL DEVICE CLASSIFICATION
TABLE 35 TYPES OF PMA SUPPLEMENTS
TABLE 36 MEDICAL DEVICES BY CLASS
TABLE 37 RULES AND REGULATIONS IN JAPAN
TABLE 38 REGISTRATION/APPROVAL OF PATENTS GLOBALLY 2010-2016 (%)
TABLE 39 GLOBAL BIOSURGERY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 40 NORTH AMERICA BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 41 EUROPE BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 42 ASIA-PACIFIC BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 43 REST OF WORLD BIOSURGERY MARKET 2018-2026 ($ MILLION)


FIGURES LIST
FIGURE 1 GLOBAL BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 2 LIFE EXPECTANCY OF GERIATRIC POPULATION GLOBALLY 2010-2050
FIGURE 3 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65, 2015 & 2050
FIGURE 4 PER CAPITA HEALTH EXPENDITURES FOR TOP COUNTRIES ($)
FIGURE 5 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 6 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL BIOSURGERY MARKET IN HEMOSTATIC AGENTS 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT 2018-2026 ($ MILLION)
FIGURE 9 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL BIOSURGERY MARKET IN NEURO AND SPINE SURGERY 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL BIOSURGERY MARKET IN CARDIO AND THORACIC SURGERY 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL BIOSURGERY MARKET IN GENERAL SURGERY 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL BIOSURGERY MARKET IN ORTHOPEDIC SURGERY 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL BIOSURGERY MARKET IN NATURAL 2018-2026
FIGURE 16 GLOBAL BIOSURGERY MARKET IN SYNTHETIC 2018-2026
FIGURE 17 KEY STRATEGIES IN BIOSURGERY MARKET (%)
FIGURE 18 U.S. PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 19 U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016 (%)
FIGURE 20 EUROPE PATENT ANALYSIS BY PRODUCT 2010-2016 (%)
FIGURE 21 EUROPE PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 22 JAPAN PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 23 JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 24 CHINA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 25 CHINA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 26 KOREA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 27 KOREA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 28 BIOSURGERY RESEARCH PROJECTS PATENT BY DIFFERENT ORGANIZATIONS 2016 (%)
FIGURE 29 NORTH AMERICA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 30 THE UNITED STATES BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 31 DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES (%)
FIGURE 32 CANADA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 33 MEXICO BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 34 EUROPE BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 35 RATE OF CHRONIC DISORDERS IN EUROPE 2016 (%)
FIGURE 36 GERMANY BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 37 THE UNITED KINGDOM BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 38 FRANCE BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 39 REST OF EUROPE BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 40 ASIA-PACIFIC BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 41 CHINA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 42 RATE OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN (%)
FIGURE 43 JAPAN BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 44 INDIA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 45 AUSTRALIA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 46 REST OF ASIA-PACIFIC BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 47 REST OF WORLD BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 48 LATIN AMERICA BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 49 MIDDLE EAST BIOSURGERY MARKET 2018-2026 ($ MILLION)
FIGURE 50 AFRICA BIOSURGERY MARKET 2018-2026 ($ MILLION)

List of Tables

TABLE LIST
TABLE 1 GLOBAL BIOSURGERY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 GLOBAL BIOSURGERY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 5 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 6 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY TYPES 2018-2026 ($ MILLION)
TABLE 7 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 8 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN SYNTHETIC GRAFT EXTENDERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN DEMINERALIZED BONE MATRIX BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 10 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN BONE MORPHOGENETIC PROTEINS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 GLOBAL BONE-GRAFT SUBSTITUTES MARKET IN CELL-BASED MATRICES BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 12 GLOBAL BIOSURGERY MARKET IN HEMOSTATIC AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 13 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 15 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 16 GLOBAL SOFT-TISSUE MANAGEMENT MARKET IN BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 17 GLOBAL SOFT-TISSUE MANAGEMENT MARKET IN BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 18 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 19 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 20 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 21 GLOBAL SURGICAL SEALING AGENTS MARKET IN NATURAL BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 22 GLOBAL SURGICAL SEALING AGENTS MARKET IN SYNTHETIC BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 23 GLOBAL BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 24 GLOBAL BIOSURGERY MARKET BY APPLICATIONS 2018-2026 ($ MILLION)
TABLE 25 GLOBAL BIOSURGERY MARKET IN NEURO AND SPINE SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 26 GLOBAL BIOSURGERY MARKET IN CARDIO AND THORACIC SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 27 TYPES OF CARDIOVASCULAR DISEASES
TABLE 28 GLOBAL BIOSURGERY MARKET IN GENERAL SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 29 GLOBAL BIOSURGERY MARKET IN ORTHOPEDIC SURGERY BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 30 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 31 GLOBAL BIOSURGERY MARKET BY SOURCE TYPE 2018-2026
TABLE 32 GLOBAL BIOSURGERY MARKET IN NATURAL BY GEOGRAPHY 2018-2026
TABLE 33 GLOBAL BIOSURGERY MARKET IN SYNTHETIC BY GEOGRAPHY 2018-2026
TABLE 34 MEDICAL DEVICE CLASSIFICATION
TABLE 35 TYPES OF PMA SUPPLEMENTS
TABLE 36 MEDICAL DEVICES BY CLASS
TABLE 37 RULES AND REGULATIONS IN JAPAN
TABLE 38 REGISTRATION/APPROVAL OF PATENTS GLOBALLY 2010-2016 (%)
TABLE 39 GLOBAL BIOSURGERY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 40 NORTH AMERICA BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 41 EUROPE BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 42 ASIA-PACIFIC BIOSURGERY MARKET 2018-2026 ($ MILLION)
TABLE 43 REST OF WORLD BIOSURGERY MARKET 2018-2026 ($ MILLION)

Companies Mentioned

1. B. BRAUN MELSUNGEN AG
2. BAXTER INTERNATIONAL INC.
3. ETHICON INC.
4. EXATECH INC
5. JOHNSON & JOHNSON
6. MEDTRONIC PLC
7. OLYMPUS CORPORATION
8. RTI SURGICAL
9. SANOFI
10. SMITH & NEPHEW PLC
11. STRYKER CORPORATION
12. WRIGHT MEDICAL GROUP N.V.
13. YPSOMED HOLDING AG
14. ZIMMER BIOMET HOLDINGS INC.

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る